ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,387Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 546

$809K Total Retail Price of All Prescriptions

Rank: 9 out of 546

403 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 403 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 403 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 12,766 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 725 692 1 3
METOPROLOL TARTRATE 634 603 2 6
SERTRALINE HCL 568 507 3 14
FUROSEMIDE 492 453 4 5
LISINOPRIL 438 423 5 1
WARFARIN SODIUM 430 389 6 13
OMEPRAZOLE 340 325 7 4
TRAZODONE HCL 324 295 8 25
RISPERIDONE 297 251 9 47
SIMVASTATIN 297 251 9 2
HYDROCODONE-ACETAMINOPHEN 290 242 S3 11 8
CITALOPRAM HBR 271 242 12 21
GABAPENTIN 250 201 13 16
NAMENDA 247 246 14 60
METOPROLOL SUCCINATE 241 230 15 17
AMLODIPINE BESYLATE 236 236 16 9
DONEPEZIL HCL 228 227 17 31
CYMBALTA 220 198 18 37
TRAMADOL HCL 187 181 19 19
POTASSIUM CHLORIDE 186 156 20 30
MIRTAZAPINE 183 172 21 51
SPIRIVA 153 144 22 28
QUETIAPINE FUMARATE 144 111 23 72
ISOSORBIDE MONONITRATE ER 143 136 24 32
ADVAIR DISKUS 141 124 25 20
NYSTATIN 136 123 26 97
NOVOLOG FLEXPEN 122 113 27 176
GLIPIZIDE 122 111 27 44
LEVEMIR FLEXPEN 121 100 29 130
ATENOLOL 107 105 30 12
CARBIDOPA-LEVODOPA 101 101 31 76
LIDODERM 99 94 32 73
NOVOFINE AUTOCOVER 98 76 33 206
OXYCODONE HCL 94 88 S2 34 15
ESCITALOPRAM OXALATE 94 93 34 66
DIVALPROEX SODIUM 92 76 36 78
LEVETIRACETAM 89 59 37 95
DIGOXIN 88 88 38 62
OLANZAPINE 87 62 39 103
HALOPERIDOL 86 84 40 102
LANTUS 84 79 41 46
LOSARTAN POTASSIUM 80 71 42 24
ATORVASTATIN CALCIUM 79 68 43 11
DILTIAZEM 24HR CD 79 79 43 91
PREDNISONE 74 73 45 29
MORPHINE SULFATE 72 49 S2 46 138
LYRICA 72 52 46 69
LACTULOSE 71 66 48 96
RANITIDINE HCL 68 56 49 23
FLUTICASONE PROPIONATE 65 62 50 42
BUMETANIDE 64 55 51 127
FENTANYL 63 49 S2 52 50
LAMOTRIGINE 61 53 53 125
DIOVAN 60 58 54 65
VENLAFAXINE HCL ER 56 56 55 88
HYDROCHLOROTHIAZIDE 55 55 56 7
ALLOPURINOL 54 53 57 41
LUMIGAN 54 46 57 196
CIPROFLOXACIN HCL 53 48 59 84
CLOPIDOGREL 52 52 60 77
TIMOLOL MALEATE 50 37 61 246
CARBAMAZEPINE 50 22 61 120
BACLOFEN 50 20 61 86
DIVALPROEX SODIUM ER 50 12 61 246
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.